Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2026-01-07 @ 12:26 PM
Study NCT ID:
NCT02544633
Status:
COMPLETED
Last Update Posted:
2020-03-04
First Post:
2015-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
Sponsor:
Mirati Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10
Start Date Type:
None
Primary Completion Date:
2018-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-04
First Submit QC Date:
None
Study First Post Date:
2015-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-30
Results First Submit QC Date:
None
Results First Post Date:
2019-09-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-19
Last Update Post Date:
2020-03-04
Last Update Post Date Type:
ACTUAL